Publications:

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Oncotarget

Cabezón, Marta M; Bargay, Joan J; Xicoy, Blanca B; García, Olga O; Borrás, Josep J; Tormo, Mar M; Marcé, Sílvia S; Pedro, Carme C; Valcárcel, David D; Jiménez, Maria-José MJ; Guàrdia, Ramón R; Palomo, Laura L; Brunet, Salut S; Vall-Llovera, Ferran F; Garcia, Antoni A; Feliu, Evarist E; Zamora, Lurdes L; ,

Publication Date: 2018-04-10

Variant appearance in text: NF1: 2141G>C

PubMed Link: 29721207

Variant Present in the following documents:

• Main text
• oncotarget-09-19342.pdf

View BVdb publication page